Diagnostics & Diseases Market Research Reports & Industry Analysis

... and 103 tables. The report explores future trends in the Italian market; provides estimates of the specimen, test and sales volumes, ... segment: Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review ...

... and 103 tables. The report explores future trends in the Japanese market; provides estimates of the specimen, test and sales volumes ... segment: Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review ...

... pages and 117 tables. The report explores future trends in the Spanish market; provides estimates of the specimen, test and sales volumes, ... /Private Laboratories Ambulatory Care Centers Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review ...

... , cancer, immunoprotein and abused drug assays, by market segment: Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and a feature comparison of high-, ...

... abused drug assays, by market segment: Hospitals Commercial/Private Laboratories Physician Offices/Group Practices Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and a feature comparison of ...

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Commercial/Private Laboratories Military Blood Banks Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

... and potential market entrants identify and evaluate emerging opportunities in the European transfusion diagnostic market during the next five years, and assist ... B19 NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ...

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Centers Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Centers Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Centers Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Centers Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Centers Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Centers Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Commercial/Private Laboratories Military Blood Banks Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

... Oral IFN –Free combinations for Treatment of HCV and ROW opportunity Competitive Landscape - IFN-Free drugs HCV Vaccines and their progress Difficult to treat and drugs for HCV-HIV co infection Market ...

... be done to improve how these predictive tools can be used? This week's Physician Views poll asks oncologists based in the US and 5EU markets: How many cancer patients they assess with a companion diagnostic prior to treatment? How the ...

The global market for colorectal cancer (CRC) drugs is undergoing a fundamental shift due to wider generic competition in ... clinical opinion This new KOL Insight report Colorectal Cancer - EGFR inhibitors on the verge of growth provides everyone interested in this dynamic cancer sector with a complete ...

... and development of small molecule and siRNA/miRNA inhibitors of the Pim Kinases. In addition, the report lists company-specific R&D pipelines of Pim Kinase inhibitors. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of Compound, ...

Complete report $33,500. DataPack (test volumes, sales forecasts, supplier shares) $21,800. “2014 Opportunities in the Global Clinical Chemistry and Immunodiagnostics Markets” is a new seven-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic ...

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. '2014 Opportunities in the European Clinical Chemistry and Immunodiagnostics Markets' is a new five-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic ...

... 100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the French Clinical Chemistry and Immunodiagnostics Markets” is a new strategic ... the next five years. The report explores future trends in the French market; provides estimates of the specimen, test and sales volumes ...

... 100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the German Clinical Chemistry and Immunodiagnostics Markets” is a new strategic ... the next five years. The report explores future trends in the German market; provides estimates of the specimen, test and sales volumes ...

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the Italian Clinical Chemistry and Immunodiagnostics Markets” is a new strategic analysis of major business opportunities emerging in the Italian clinical chemistry and immunodiagnostic markets ...

... 600. DataPack (test volumes, sales forecasts, supplier shares) $4,900. “2014 Opportunities in the Japanese Clinical Chemistry and Immunodiagnostics Markets” is a new strategic ... next five years. The report explores future trends in the Japanese market; provides estimates of the specimen, test and sales volumes ...

... 100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the Spanish Clinical Chemistry and Immunodiagnostics Markets” is a new strategic ... next five years. The report explores future trends in the Spanish market; provides estimates of the specimen, test and sales volumes, ...

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the UK Clinical Chemistry and Immunodiagnostics Markets” is a new strategic analysis of major business opportunities emerging in the UK clinical chemistry and immunodiagnostic markets during the ...

Complete report $11,500. DataPack (test volumes, sales forecasts, supplier shares) $7,500 “2014 Opportunities in the US Clinical Chemistry and Immunodiagnostics Markets” is a new strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic markets during the ...

... of the therapies for Multiple Myeloma (Newly diagnosed - NDMM and relapsed/ refractory - RRMM), unmet need, and limitations of the current standard of ... care (SoC) for relapsed and refractory MM pts. The report highlights the competition and commercial opportunity ...

... antibody inhibitors of the Wnt ligand or its receptors Frizzled and LRP5/6 in oncology. In addition, the report lists company-specific R&D pipelines of Wnt pathway inhibitors. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of ...

... market entrants identify and evaluate emerging opportunities in the European transfusion diagnostic market during the next five years, and assist industry ... and technological trends in the Europe; provides test volume and sales forecasts by market segment/test location; compares features of major automated ...

... market entrants identify and evaluate emerging opportunities in the French transfusion diagnostic market during the next five years, and assist industry ... , new product development and marketing strategies. The report explores future marketing and technological trends in France; provides test volume and sales ...

... market entrants identify and evaluate emerging opportunities in the German transfusion diagnostic market during the next five years, and assist industry ... , new product development and marketing strategies. The report explores future marketing and technological trends in Germany; provides test volume and ...

... market entrants identify and evaluate emerging opportunities in the global transfusion diagnostic market during the next five years, and assist industry ... ; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood ...

... market entrants identify and evaluate emerging opportunities in the Italian transfusion diagnostic market during the next five years, and assist industry ... , new product development and marketing strategies. The report explores future marketing and technological trends in Italy; provides test volume and sales ...

... market entrants identify and evaluate emerging opportunities in the Japanese transfusion diagnostic market during the next five years, and assist industry ... , new product development and marketing strategies. The report explores future marketing and technological trends in Japan; provides test volume and ...

... entrants identify and evaluate emerging opportunities in the US transfusion diagnostic market during the next five years, and assist industry executives in ... and technological trends in US; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi- ...

... has the largest share of the overall vaccines and specifically cancer vaccines market. This is followed by Europe and Asia. North America and ... process. Following parameters for each vaccine profile in development phase are covered in “Global Cancer Vaccines Pipeline Analysis” research report: Drug Profile ...

... Ingelheim's Pradaxa was not a widely held view FirstWord Pharma PLUS subscribers can view the results and analysis from this poll ... . This week's FirstWord Physician Views poll will ask: How do the clinical profiles of oral anticoagulants compare with warfarin? How does the clinical profile ...

The present Competitive Intelligence report about Bruton’s Tyrosine Kinase (BTK) Inhibitorsprovides a competitor evaluation in the field of small molecule-based inhibitors of Bruton’s Tyrosine Kinase (BTK) for the treatment of B-cell related hematologic malign ancies and autoimmune diseases as of August 2013. ...

The present Competitive Intelligence report about Focal Adhesion Kinase (FAK) Inhibitors provides a competitor evaluation in the field of small molecule-based ... and development of selective and multi-target small molecule Focal Adhesion Kinase (FAK) inhibitors in oncology. In addition, the report lists company ...

... of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. ... Recommendations Specific new product development opportunities with potentially significant market appeal during the next five years. Design criteria for ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the French cancer diagnostics ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the German cancer diagnostics ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Italian cancer diagnostics ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Japanese cancer ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Spanish cancer diagnostics ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the UK cancer ...

... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the US cancer ...

The present Competitive Intelligence report about Anaplastic Lymphoma Kinase (ALK) Inhibitors provides a competitor evaluation in the field of small molecule and antibody-based inhibitors of Anaplastic Lymphoma Kinase (ALK) for the treatment of solid tumors as of August 2013. Purchase ...